{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:46:43Z","timestamp":1761216403913,"version":"3.41.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1023\/a:1007879704878","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T11:54:20Z","timestamp":1040558060000},"page":"525-530","source":"Crossref","is-referenced-by-count":12,"title":["Cardioprotective Efficacy of Verapamil and Mibefradil in Young UM-X7.1 Cardiomyopathic Hamsters"],"prefix":"10.1007","volume":"13","author":[{"given":"France","family":"Paquette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtan","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"241638_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1527-3466.1991.tb00539.x","volume":"9","author":"JP Clozel","year":"1991","unstructured":"Clozel JP, Osterrieder W, Kleinbloesen CH, et al. Ro 40\u20135967: A new nondihydropyridine calcium antagonist. Cardiovasc Drugs Rev 1991;9:4\u201317.","journal-title":"Cardiovasc Drugs Rev"},{"key":"241638_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00005344-198913050-00011","volume":"13","author":"W Osterrieder","year":"1989","unstructured":"Osterrieder W, Holck M. In vitro pharmacologic profile of Ro 40\u20135967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol 1989;13:754\u2013759.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00005344-199308000-00019","volume":"22","author":"K Orito","year":"1993","unstructured":"Orito K, Satoh K, Taira N. Cardiovascular profile of Ro 40\u20135967, a new non-dihydropyridine calcium antagonist delineated in isolated blood-perfused dog hearts. J Cardiovasc Pharmacol 1993;22:293\u2013299.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00005344-199608000-00014","volume":"28","author":"D Karila-Cohen","year":"1996","unstructured":"Karila-Cohen D, Dubois-Rand\u00e9 JL, Giudicelli JF, Berdeaux A. Effects of mibefradil on large and small coronary arteries in conscious dogs: Role of the vascular endothelium. J Cardiovasc Pharmacol 1996;28:271\u2013277.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF01856562","volume":"4","author":"JP Clozel","year":"1990","unstructured":"Clozel JP, V\u00e9niant M, Osterrieder W. The structurally novel Ca2+ channel blocker Ro 40\u20135967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts. Cardiovasc Drugs Ther 1990;4;731\u2013736.","journal-title":"Cardiovasc Drugs Ther"},{"key":"241638_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00005344-199102000-00014","volume":"17","author":"M V\u00e9niant","year":"1991","unstructured":"V\u00e9niant M, Clozel JP, Hess P, Wolfgang R. Ro 40\u20135967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. J Cardiovasc Pharmacol 1991;17;277\u2013280.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005344-199601000-00021","volume":"27","author":"S Roux","year":"1996","unstructured":"Roux S, B\u00fchler M, Clozel JP. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: Comparison with amlodipine. J Cardiovasc Pharmacol 1996;27:132\u2013139.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00005344-198911000-00007","volume":"14","author":"JP Clozel","year":"1989","unstructured":"Clozel JP, Banken L, Osterrieder W. Effects of Ro 40\u20135967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil. J Cardiovasc Pharmacol 1989;14:713\u2013721.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00005344-199607000-00011","volume":"28","author":"J-S Li","year":"1996","unstructured":"Li J-S, Schiffrin EL. Effect of calcium blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1996;28;68\u201374.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00005344-199605000-00011","volume":"27","author":"E Vacher","year":"1996","unstructured":"Vacher E, Richer C, Fornes P, Clozel JP, Giudicelli JF. Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 1996;27;686\u2013694.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00823586","volume":"10","author":"R Schmitt","year":"1996","unstructured":"Schmitt R, Clozel JP, Iberg I, B\u00fchler FR. Prevention of neointima formation by mibefradil after vascular injury in rats: Comparison with ACE inhibition. Cardiovasc Drug Ther 1996;10;101\u2013105.","journal-title":"Cardiovasc Drug Ther"},{"key":"241638_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.RES.75.1.149","volume":"75","author":"L Sen","year":"1994","unstructured":"Sen L, Smith TW. T-Type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994;75:149\u2013155.","journal-title":"Circ Res"},{"key":"241638_CR13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.CIR.66.2.342","volume":"66","author":"SM Factor","year":"1982","unstructured":"Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circulation 1982;66:342\u2013354.","journal-title":"Circulation"},{"key":"241638_CR14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1139\/y84-149","volume":"62","author":"G Jasmin","year":"1984","unstructured":"Jasmin G, Proschek L. Calcium and myocardial cell injury. An appraisal in the cardiomyopathic hamster. Can J Physiol Pharmacol 1984;62:891\u2013898.","journal-title":"Can J Physiol Pharmacol"},{"key":"241638_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mus.880050105","volume":"5","author":"G Jasmin","year":"1982","unstructured":"Jasmin G, Proschek L. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Muscle and Nerve 1982;5:20\u201325.","journal-title":"Muscle and Nerve"},{"key":"241638_CR16","first-page":"114","volume-title":"Pathological Techniques","author":"FB. Mallory","year":"1961","unstructured":"Mallory FB. Von Kossa's method for calcium. In: Pathological Techniques. New York: Hafner, 1961:114\u2013125."},{"key":"241638_CR17","first-page":"46","volume":"317","author":"G Jasmin","year":"1979","unstructured":"Jasmin G, Eu HY. Cardiomyopathy of hamster dystrophy. Ann NY Acad Sci 1979;317:46\u201358.","journal-title":"Ann NY Acad Sci"},{"key":"241638_CR18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0002-8703(69)90556-0","volume":"77","author":"E. Bajusz","year":"1969","unstructured":"Bajusz E. Hereditary cardiomyopathy: A new disease model. Am Heart J 1969;77:686\u2013696.","journal-title":"Am Heart J"},{"key":"241638_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1749-6632.1979.tb37318.x","volume":"317","author":"F. Hamburger","year":"1979","unstructured":"Hamburger F. Myopathy of hamster dystrophy: History and morphological aspects. Ann NY Acad Sci 1979;317:2\u201317.","journal-title":"Ann NY Acad Sci"},{"key":"241638_CR20","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1016\/S0021-9258(19)50225-3","volume":"268","author":"SL Roberds","year":"1993","unstructured":"Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J Biol Chem 1993;268:11496\u201311499.","journal-title":"J Biol Chem"},{"key":"241638_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/01.RES.69.1.123","volume":"69","author":"O Hano","year":"1991","unstructured":"Hano O, Lakatta EG. Diminished tolerance of prehypertrophic cardiomyopathic Syrian hamster hearts to Ca2+ stress. Circ Res 1991;69:123\u2013133.","journal-title":"Circ Res"},{"key":"241638_CR22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.RES.37.6.855","volume":"37","author":"MJ Sole","year":"1975","unstructured":"Sole MJ, Lo C-M, Laird CW, Sonnenblick EH, Wurtman RJ. Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster. Circ Res 1975;37;855\u2013862.","journal-title":"Circ Res"},{"issue":"Suppl3","key":"241638_CR23","first-page":"159","volume":"76","author":"B Kundel","year":"1987","unstructured":"Kundel B, Hofmann U, Mutschler M. Comparison of verapamil and bepridil in the therapy of familiar cardiomyopathy of the Syrian hamster. Z. Kardiol 1987;76(Suppl 3):159\u2013613.","journal-title":"Z. Kardiol"},{"key":"241638_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.880050114","volume":"5","author":"YH Bhattacharya","year":"1982","unstructured":"Bhattacharya YH, Palmieri EA, Bertorini UE, Nuting DF. The effects of diltiazem on dystrophic hamsters. Muscle and Nerve 1982;5:73\u201378.","journal-title":"Muscle and Nerve"},{"key":"241638_CR25","first-page":"79","volume-title":"Pathogenesis of Myocarditis and Cardiomyopathy","author":"G Jasmin","year":"1987","unstructured":"Jasmin G, Proschek L. Pathogenesis of the hamster hereditary cardiomyopathy: a pharmacologic appraisal. In: Kawai C, Abelmann WH (eds). Pathogenesis of Myocarditis and Cardiomyopathy. Tokyo: University of Tokyo Press, 1987:79\u201389."},{"key":"241638_CR26","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0735-1097(88)80031-7","volume":"12","author":"SM Factor","year":"1988","unstructured":"Factor SM, Cho S, Scheuer J, Sonnenblick EH, Malhotra A. Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy. J Am Coll Cardiol 1988;12:1599\u20131604.","journal-title":"J Am Coll Cardiol"},{"key":"241638_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-85376-0_2","volume-title":"Treatment with Gallopamil","author":"G Jasmin","year":"1989","unstructured":"Jasmin G, Proschek L. Comparative effects of calcium antagonists and of inotropic agents on the development of hereditary cardiomyopathy in the hamster. In: Bender F, Meesmann W (eds). Treatment with Gallopamil. Darmstadt: Steinkoff Verlag, 1989:13\u201323."},{"key":"241638_CR28","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0022-3565(25)24034-4","volume":"271","author":"G Mehrke","year":"1994","unstructured":"Mehrke G, Zong XG, Flockerzi V, Hofmann F. The Ca2+ channel blocker Ro 40\u20135967 blocks differently T-type and L-type Ca2+ channels. J Pharmacol Exp Ther 1994;271:1483\u20131488.","journal-title":"J Pharmacol Exp Ther"},{"key":"241638_CR29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.RES.75.1.144","volume":"75","author":"SK Mirsha","year":"1994","unstructured":"Mirsha SK, Hermsmeyer K. Selective inhibition of T-type Ca2+ channels by Ro 40\u20135967. Circ Res 1994;75:144\u2013148.","journal-title":"Circ Res"},{"key":"241638_CR30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/01.CIR.76.1.208","volume":"76","author":"HR Figulla","year":"1987","unstructured":"Figulla HR, Vetterlein F, Glaubitz M, Kreuzer H. Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster. Circulation 1987;76:208\u2013216.","journal-title":"Circulation"},{"key":"241638_CR31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/cvr\/28.3.320","volume":"28","author":"RS Conway","year":"1994","unstructured":"Conway RS, Natelson BH, Chen WH, Ting W. Enhanced coronary vasoconstriction in the Syrian myopathic hamster supports the microvascular spasm hypothesis. Cardiovasc Res 1994;28:320\u2013324.","journal-title":"Cardiovasc Res"},{"key":"241638_CR32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00005344-199508000-00018","volume":"26","author":"CF K\u00fcng","year":"1995","unstructured":"K\u00fcng CF, Tschudi MR, Noll G, Clozel JP, L\u00fcscher TF. Differential effects of the calcium antagonist mibefradil in epicardial and intramyocardial coronary arteries. J Cardiovasc Pharmacol 1995;26:312\u2013318.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005344-199407000-00001","volume":"24","author":"SK Mishra","year":"1994","unstructured":"Mishra SK, Hermsmeyer K. Inhibition of signal Ca++ in dog coronary arterial vascular muscle cells by Ro 40\u20135967. J Cardiovasc Pharmacol 1994;24:1\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"key":"241638_CR34","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0022-3565(25)13103-0","volume":"277","author":"GE Billman","year":"1996","unstructured":"Billman GE, Hamlin RL. The effects of mibefradil, a novel calcium channel antagonist, on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation. J Pharmacol Exp Ther 1996;277:1517\u20131526.","journal-title":"J Pharmacol Exp Ther"},{"key":"241638_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cvr\/25.1.49","volume":"25","author":"O Hano","year":"1991","unstructured":"Hano O, Mitsuoka T, Matsumoto Y, et al. Arrhythmogenic properties of the ventricular myocardium in the cardiomyopathic Syrian hamster, BIO 14.6 strain. Cardiovasc Res 1991;25:49\u201357.","journal-title":"Cardiovasc Res"},{"key":"241638_CR36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.RES.67.6.1381","volume":"67","author":"JM Capasso","year":"1990","unstructured":"Capasso JM, Sonnenblick EH, Anversa P. Chronic calcium channel blockade prevents the progression of myocardial contractile and electrical dysfunction in the cardiomyopathic Syrian hamster. Circ Res 1990;67:1381\u20131393.","journal-title":"Circ Res"},{"key":"241638_CR37","first-page":"953","volume":"46","author":"EI Rathner","year":"1996","unstructured":"Rathner EI, Bochkov VN, Tkachuk VA. Comparison of binding of 3H-desmethoxyverapamil and 3H-mibefradil in vascular smooth muscle and heart membranes. Drug Res 1996;46:953\u2013955.","journal-title":"Drug Res"},{"key":"241638_CR38","doi-asserted-by":"crossref","first-page":"4C","DOI":"10.1016\/S0002-9149(97)00564-X","volume":"80","author":"DR Abernethy","year":"1997","unstructured":"Abernethy DR. Pharmacologic and pharmacokinetic profile of mibefradil, a T-and L-type calcium channel antagonist. Am J Cardiol 1997;80:4C\u201311C.","journal-title":"Am J Cardiol"},{"key":"241638_CR39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2165\/00003088-199222060-00002","volume":"22","author":"JG Kelly","year":"1992","unstructured":"Kelly JG, O'Malley K. Clinical pharmacokinetics of calcium antagonists. An update. Clin Pharmacokin 1992;22:416\u2013433.","journal-title":"Clin Pharmacokin"},{"key":"241638_CR40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.880050106","volume":"5","author":"L Proschek","year":"1982","unstructured":"Proschek L, Jasmin G. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function. Muscle and Nerve 1982;5:26\u201332.","journal-title":"Muscle and Nerve"},{"key":"241638_CR41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/jmcc.1994.1041","volume":"26","author":"JL Saap","year":"1994","unstructured":"Saap JL, Howlett SE. Density of ryanodine receptors is increased in sarcoplasmic reticulum from prehypertrophic cardiomyopathic hamster heart. J Mol Cell Cardiol 1994;26:325\u2013334.","journal-title":"J Mol Cell Cardiol"},{"key":"241638_CR42","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpcell.1998.274.1.C1","volume":"274","author":"T Ueyama","year":"1998","unstructured":"Ueyama T, Ohkusa T, Hisamatsu Y, et al. Alterations in cardiac SR Ca2+ channels during development of heart failure in cardiomyopathic hamsters. Am J Physiol 1998;274:H1\u2013H7.","journal-title":"Am J Physiol"},{"key":"241638_CR43","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0026-895X(25)09217-X","volume":"42","author":"G. Zerning","year":"1992","unstructured":"Zerning G. Photoaffinity labeling of the partially purified mitochondrial phenylalkylamine calcium antagonist receptor. Mol Pharmacol 1992;42:1010\u20131013.","journal-title":"Mol Pharmacol"},{"key":"241638_CR44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0006-3495(90)82392-4","volume":"58","author":"HH Valdivia","year":"1990","unstructured":"Valdivia HH, Valdivia C, Ma J, Coronado R. Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum. Biophys J 1990;58:471\u2013481.","journal-title":"Biophys J"},{"key":"241638_CR45","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0024-3205(93)90432-3","volume":"52","author":"MS Finkel","year":"1993","unstructured":"Finkel MS, Shen L, Oddis CV, Romeo R. Verapamil regulation of the defective SR release channel in the cardiomyopathic Syrian hamster. Life Sci 1993;52:1109\u20131119.","journal-title":"Life Sci"},{"key":"241638_CR46","first-page":"417","volume":"40","author":"F Hefti","year":"1990","unstructured":"Hefti F, Clozel J-P, Osterrieder W. Antihypertensive properties of the novel calcium antagonist (1S,2S-2-[2-[[3-(2-benzimidazolly) propyl] methylamino] ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in the rat models. Comparison with verapamil. Drug Res 1990;40:417\u2013421.","journal-title":"Drug Res"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007879704878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007879704878\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007879704878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:25:49Z","timestamp":1751052349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007879704878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["241638"],"URL":"https:\/\/doi.org\/10.1023\/a:1007879704878","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}